SlideShare a Scribd company logo
Hyponatraemia John Foote Causes, assessment and management
Hyponatraemia Definitions Significance Pathophysiology Investigation and assessment Management
Acute Hyponatreamia Hyponatraemia which has developed in less than 12-24 hours Leads to water migration from ECF to ICF Clinical issue is with cerebral swelling Symptomatic at  <  125 mmol/l
Acute Hyponatraemia and Cerebral Swelling Hyponatreamia Normal
Symptoms of Acute Hyponatraemia Nausea/vomiting Headache Muscular twitching Cognitive impairment Psychosis Convulsions Coma
Chronic Hyponatraemia Hyponatreamia which has developed over more than 24 hours ICF solute discarded to match reduced ECF sodium loss Water distribution between ICF and ECF is undisturbed
Chronic Hyponatraemia Symptoms develop due to neuronal electrolyte depletion with serum [Na + ] at about 115 mmol/l Rapid correction of hyponatraemia leads to brain shrinkage and risk of central pontine myelinolysis
Central Pontine Myelinolysis Onset occurs 24-48 hours after the over-rapid correction of hyponatraemia Devastating neurological deficit Quadraparesis Psuedobulbar palsy Mutism Convulsions Malnourished or alcohol dependent patients at very high risk
Water Homeostasis Plasma Osmolality (mOsmol/Kg) Oral water intake Renal water clearance 270 280 290 300
Osmolar Control of ADH Secretion 270 280 290 300 Plasma Osmolality (mOsmol/Kg) Plasma ADH
Non-osmolar Stimulation of ADH Secretion Hypovolaemia Systemic hypotension Trauma Highly potent mechanism Non-osmolar stimuli are implicated in 95% of cases of severe hyponatraemia
Response to Vascular Volume Deficit Vascular volume deficit Osmolar ADH control Non-osmolar ADH control Vascular volume maintained at the cost of ECF dilution Volume deficit
Investigation Pitfall Urine : serum osmolality measurements which are ‘inappropriately raised’ are non-specific, are often over-reported on laboratory reports, and can be misleading
Diagnosis and Assessment Serum sodium concentrations reflect the ratio between water and sodium content of ECF rather than the absolute amount of either In clinical practice hyponatraemia is usefully classified as hypovolaemic, normovolaemic and hypervolaemic types
Diagnosis and Assessment The underlying aetiology will remain unknown in about 50% of cases of hyponatraemia Correct management can be instituted if hyponatraemia is correctly classified, whatever the aetiology
Diagnosis and Assessment To correctly classify hyponatraemia it is necessary to: Take a history Establish if vascular volume is increased, reduced or normal Interpret the results of relevant laboratory investigations in the light of the above
Hyponatreamia? Plasma osmolality     2.[Na + ] + 2.[K + ] + [Urea] + [Glucose] Osmolality can be effective or ineffective Serum osmolality? Pseudohyponatraemia ‘ Drip’ artefact Normal or Raised Hyperglycaemia Mannitol therapy Radiographic contrast
Pseudohyponatraemia Normo-osmolar Hyponatraemia Normal Pseudohyponatraemia 7% 20% 93% 80% [Na + ] plasma water: 150 mmol/l 150 mmol/l [Na + ] whole plasma: 140 mmol/l 120 mmol/l Non-aqueous phase Aqueous phase
Renal sodium losses GI fluid losses Skin fluid losses Haemorrhage Heart failure Liver failure Nephrotic syndrome SIADH Other causes of  renal water retention Hyponatreamia? True Hyponatreamia Low Increased Normal Reduced Volume status? Serum osmolality? Pseudohyponatraemia ‘ Drip’ artefact Normal or Raised Hyperglycaemia Mannitol therapy Radiographic contrast
Management of Hyponatraemia True Hyponatreamia Correct underlying cause Resuscitate with 0.9% saline Optimise treatment of underlying disease Restrict salt and water Diuretics Specific treatment for non-SIADH states or for SIADH Increased Normal Reduced Volume status?
Causes of Dilutional Hyponatraemia Renal insensitivity to ADH suppression Renal failure ACTH deficiency Thyroid failure Reset osmostat - K +  deficiency Non-osmotic ADH secretion SIADH
Criteria for Diagnosis of SIADH Hypo-osmolar hyponatraemia Clinical euvolaemia Osmolality  (urine)  > Osmolality  (plasma)   [Na + ]  (urine)  > 30 mmol/l Normal renal function No deficiency of cortisol or thyroxine No non-osmotic cause for ADH secretion
Management of SIADH Correct underlying cause Residual mild hyponatraemia  (Na >125 mmol/l) can be left untreated Water restriction 500-1000 ml/day Demeclocycline 600 mg/day
Management of Non-SIADH Dilutional Hyponatraemia Renal insensitivity to ADH suppression Renal failure ACTH deficiency Thyroid failure Reset osmostat - K +  deficiency Non-osmotic ADH secretion
Severe Symptomatic Hyponatraemia Patients suffer double jeopardy of a pressure cone on one hand and CPM on the other Rapid correction is indicated with hyponatraemia known to be acute (12-24 hours), or in the presence of neurological symptoms Otherwise serum sodium correction should be limited to no more than 0.5 mmol/l/hour in the first 48 hours
Is Serum [Na + ] < 125 mmol/l?  Neurological symptoms?  Duration of hyponatraemia?  Yes Chronic hyponatraemia  Yes No Emergency correction with 3% saline 1-2 ml/kg/hour until [Na] > 125 mmol/l  Urgent correction with 3% saline 1-2 ml/kg/hour until symptoms resolve, continue at 0.5 mmol/l/hour thereafter  <24 h >24 h or unknown Routine assessment and management No Adverse outcome unlikely
Hypertonic Saline Therapy Start with 3% saline at 100 ml/hour 100 ml of 3% saline can be expected to increase serum [Na + ] by 2 mmol/l Formulae to estimate the correction doses of iv saline are unreliable Titrate the infusion rate on the basis of hourly serum [Na + ] measurements
Problems Over-reliance on laboratory data Misclassification leading to the over-diagnosis of SIADH Inappropriate application of therapies Inadequate clinical supervision and laboratory monitoring
Future Treatments Vasopressin (V2) receptor antagonists: Highly effective in SIADH and volume expanded hyponatraemia Standard rules for correction rates apply Hyponatraemia relapses on cessation Phenomenally expensive

More Related Content

PPTX
Interpretation of Routine Laboratory investigations in General practice
PPTX
Acute pancreatitis
PPTX
Pathophysiology of acute kidney injury
PPT
Quality Assurance
PDF
ACUTE KIDNEY INJURY pqs.pdf
PPTX
Pharmaceutical Audits
PPTX
Approach to a case of aki
PPT
Interpretation of Routine Laboratory investigations in General practice
Acute pancreatitis
Pathophysiology of acute kidney injury
Quality Assurance
ACUTE KIDNEY INJURY pqs.pdf
Pharmaceutical Audits
Approach to a case of aki

What's hot (20)

PPTX
Case-Based Approach To Crohn’s Disease.pptx
PPTX
Acute Kidney Injury
PPT
Hepatorenal syndrome
PPTX
Circi .ppt
PPT
Gout
PPTX
Process improvment
PPT
Peptic Ulcer Disease.Ppt.Fmdrl
PPTX
Factory Acceptance Test( FAT).pptx .
PDF
CHAPTER-1 Management Audit and Planning procedure.pdf
PPTX
renal function tests by Dr siva kumar
PPT
Acute pancreatitis
PPTX
Acute renal failure
PPTX
Acute pancreatitis
PPT
Acute pancreatitis
PDF
PRODUCTION PLANNING AND CONTROL
PPT
Audit Check List
PPTX
Upper GI Bleeding
PPTX
GMP Auditing.pptx.......................
PDF
Core cases in Gastroenterology
PPT
Quality audits
Case-Based Approach To Crohn’s Disease.pptx
Acute Kidney Injury
Hepatorenal syndrome
Circi .ppt
Gout
Process improvment
Peptic Ulcer Disease.Ppt.Fmdrl
Factory Acceptance Test( FAT).pptx .
CHAPTER-1 Management Audit and Planning procedure.pdf
renal function tests by Dr siva kumar
Acute pancreatitis
Acute renal failure
Acute pancreatitis
Acute pancreatitis
PRODUCTION PLANNING AND CONTROL
Audit Check List
Upper GI Bleeding
GMP Auditing.pptx.......................
Core cases in Gastroenterology
Quality audits
Ad

Similar to Hyponatreamia (20)

PPTX
Hyponatremia and hypernatremia
PDF
hyponatremiaandhypernatremia-160310202741.pdf
PPTX
Na and mg disorders 2
PPTX
Hypo &hpernatrimia
PPTX
SODIUM HOMEOSTASIS
PPT
Hyopna 9090909
PPT
Hyopna 9090909
PPT
Hyopna 9090909
PPT
Hyopna 9090909
PPTX
Sodium Imbalances in NEURO ICU.pptx
PPTX
Assessment and treatment of acute hyponatraemia
PPT
Hyponatremia 040113 (1)
PPT
Hyponatremia 040113.ppt
PPT
Electrolyte disturbances
PPSX
Hyponatremia
PPT
Hyponatremia
PPT
Hyponatremia
PPT
Approach to hyponatremia
PDF
sodium disorders (Hyponatremia and hypernatremia)
PPTX
hyponatremia final.pptx
Hyponatremia and hypernatremia
hyponatremiaandhypernatremia-160310202741.pdf
Na and mg disorders 2
Hypo &hpernatrimia
SODIUM HOMEOSTASIS
Hyopna 9090909
Hyopna 9090909
Hyopna 9090909
Hyopna 9090909
Sodium Imbalances in NEURO ICU.pptx
Assessment and treatment of acute hyponatraemia
Hyponatremia 040113 (1)
Hyponatremia 040113.ppt
Electrolyte disturbances
Hyponatremia
Hyponatremia
Hyponatremia
Approach to hyponatremia
sodium disorders (Hyponatremia and hypernatremia)
hyponatremia final.pptx
Ad

More from PeninsulaEndocrine (20)

PPTX
Gestational diabetes
PPTX
Endocrine disease in pregnancy
PPTX
Diabetes in pregnancy
PPTX
Hypoglycaemia in older people
PPTX
Diabetes in the elderly
PPTX
Primary hyperaldosteronism - arterial venous sampling cases
PPT
Calcium metabolism handout
PPTX
Calcium metabolism handout
PPTX
Kallmann syndrome
PPTX
Kallmann syndrome
PPTX
Hypogonadism and testosterone replacement part 2
PPT
Hypogonadism and testosterone replacement
PPTX
Erectile dysfunction in diabetes
PPTX
The role of the podiatrist
PPTX
The diabetic foot
PPTX
ADVANCE - Type 2 diabetes - vascular risk with intervention
PPTX
DCCT/EDIC - Type 1 diabetes - cardiovascular risk with intervention
PPTX
DCCT - Hypoglycemia
PPTX
DCCT overview
PPTX
DCCT – intensive diabetes therapy and glomerular filtration
Gestational diabetes
Endocrine disease in pregnancy
Diabetes in pregnancy
Hypoglycaemia in older people
Diabetes in the elderly
Primary hyperaldosteronism - arterial venous sampling cases
Calcium metabolism handout
Calcium metabolism handout
Kallmann syndrome
Kallmann syndrome
Hypogonadism and testosterone replacement part 2
Hypogonadism and testosterone replacement
Erectile dysfunction in diabetes
The role of the podiatrist
The diabetic foot
ADVANCE - Type 2 diabetes - vascular risk with intervention
DCCT/EDIC - Type 1 diabetes - cardiovascular risk with intervention
DCCT - Hypoglycemia
DCCT overview
DCCT – intensive diabetes therapy and glomerular filtration

Recently uploaded (20)

PPTX
Note on Abortion.pptx for the student note
PPTX
CME 2 Acute Chest Pain preentation for education
PPT
Breast Cancer management for medicsl student.ppt
PPTX
History and examination of abdomen, & pelvis .pptx
PPTX
Respiratory drugs, drugs acting on the respi system
PPT
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
PPTX
post stroke aphasia rehabilitation physician
PDF
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
PPT
ASRH Presentation for students and teachers 2770633.ppt
PDF
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
PDF
Medical Evidence in the Criminal Justice Delivery System in.pdf
PPTX
Uterus anatomy embryology, and clinical aspects
PPTX
Important Obstetric Emergency that must be recognised
PDF
Human Health And Disease hggyutgghg .pdf
PPTX
1 General Principles of Radiotherapy.pptx
PPTX
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.pptx
PPTX
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PPT
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
Note on Abortion.pptx for the student note
CME 2 Acute Chest Pain preentation for education
Breast Cancer management for medicsl student.ppt
History and examination of abdomen, & pelvis .pptx
Respiratory drugs, drugs acting on the respi system
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
post stroke aphasia rehabilitation physician
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
ASRH Presentation for students and teachers 2770633.ppt
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
Medical Evidence in the Criminal Justice Delivery System in.pdf
Uterus anatomy embryology, and clinical aspects
Important Obstetric Emergency that must be recognised
Human Health And Disease hggyutgghg .pdf
1 General Principles of Radiotherapy.pptx
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.pptx
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
CHAPTER FIVE. '' Association in epidemiological studies and potential errors

Hyponatreamia

  • 1. Hyponatraemia John Foote Causes, assessment and management
  • 2. Hyponatraemia Definitions Significance Pathophysiology Investigation and assessment Management
  • 3. Acute Hyponatreamia Hyponatraemia which has developed in less than 12-24 hours Leads to water migration from ECF to ICF Clinical issue is with cerebral swelling Symptomatic at < 125 mmol/l
  • 4. Acute Hyponatraemia and Cerebral Swelling Hyponatreamia Normal
  • 5. Symptoms of Acute Hyponatraemia Nausea/vomiting Headache Muscular twitching Cognitive impairment Psychosis Convulsions Coma
  • 6. Chronic Hyponatraemia Hyponatreamia which has developed over more than 24 hours ICF solute discarded to match reduced ECF sodium loss Water distribution between ICF and ECF is undisturbed
  • 7. Chronic Hyponatraemia Symptoms develop due to neuronal electrolyte depletion with serum [Na + ] at about 115 mmol/l Rapid correction of hyponatraemia leads to brain shrinkage and risk of central pontine myelinolysis
  • 8. Central Pontine Myelinolysis Onset occurs 24-48 hours after the over-rapid correction of hyponatraemia Devastating neurological deficit Quadraparesis Psuedobulbar palsy Mutism Convulsions Malnourished or alcohol dependent patients at very high risk
  • 9. Water Homeostasis Plasma Osmolality (mOsmol/Kg) Oral water intake Renal water clearance 270 280 290 300
  • 10. Osmolar Control of ADH Secretion 270 280 290 300 Plasma Osmolality (mOsmol/Kg) Plasma ADH
  • 11. Non-osmolar Stimulation of ADH Secretion Hypovolaemia Systemic hypotension Trauma Highly potent mechanism Non-osmolar stimuli are implicated in 95% of cases of severe hyponatraemia
  • 12. Response to Vascular Volume Deficit Vascular volume deficit Osmolar ADH control Non-osmolar ADH control Vascular volume maintained at the cost of ECF dilution Volume deficit
  • 13. Investigation Pitfall Urine : serum osmolality measurements which are ‘inappropriately raised’ are non-specific, are often over-reported on laboratory reports, and can be misleading
  • 14. Diagnosis and Assessment Serum sodium concentrations reflect the ratio between water and sodium content of ECF rather than the absolute amount of either In clinical practice hyponatraemia is usefully classified as hypovolaemic, normovolaemic and hypervolaemic types
  • 15. Diagnosis and Assessment The underlying aetiology will remain unknown in about 50% of cases of hyponatraemia Correct management can be instituted if hyponatraemia is correctly classified, whatever the aetiology
  • 16. Diagnosis and Assessment To correctly classify hyponatraemia it is necessary to: Take a history Establish if vascular volume is increased, reduced or normal Interpret the results of relevant laboratory investigations in the light of the above
  • 17. Hyponatreamia? Plasma osmolality  2.[Na + ] + 2.[K + ] + [Urea] + [Glucose] Osmolality can be effective or ineffective Serum osmolality? Pseudohyponatraemia ‘ Drip’ artefact Normal or Raised Hyperglycaemia Mannitol therapy Radiographic contrast
  • 18. Pseudohyponatraemia Normo-osmolar Hyponatraemia Normal Pseudohyponatraemia 7% 20% 93% 80% [Na + ] plasma water: 150 mmol/l 150 mmol/l [Na + ] whole plasma: 140 mmol/l 120 mmol/l Non-aqueous phase Aqueous phase
  • 19. Renal sodium losses GI fluid losses Skin fluid losses Haemorrhage Heart failure Liver failure Nephrotic syndrome SIADH Other causes of renal water retention Hyponatreamia? True Hyponatreamia Low Increased Normal Reduced Volume status? Serum osmolality? Pseudohyponatraemia ‘ Drip’ artefact Normal or Raised Hyperglycaemia Mannitol therapy Radiographic contrast
  • 20. Management of Hyponatraemia True Hyponatreamia Correct underlying cause Resuscitate with 0.9% saline Optimise treatment of underlying disease Restrict salt and water Diuretics Specific treatment for non-SIADH states or for SIADH Increased Normal Reduced Volume status?
  • 21. Causes of Dilutional Hyponatraemia Renal insensitivity to ADH suppression Renal failure ACTH deficiency Thyroid failure Reset osmostat - K + deficiency Non-osmotic ADH secretion SIADH
  • 22. Criteria for Diagnosis of SIADH Hypo-osmolar hyponatraemia Clinical euvolaemia Osmolality (urine) > Osmolality (plasma) [Na + ] (urine) > 30 mmol/l Normal renal function No deficiency of cortisol or thyroxine No non-osmotic cause for ADH secretion
  • 23. Management of SIADH Correct underlying cause Residual mild hyponatraemia (Na >125 mmol/l) can be left untreated Water restriction 500-1000 ml/day Demeclocycline 600 mg/day
  • 24. Management of Non-SIADH Dilutional Hyponatraemia Renal insensitivity to ADH suppression Renal failure ACTH deficiency Thyroid failure Reset osmostat - K + deficiency Non-osmotic ADH secretion
  • 25. Severe Symptomatic Hyponatraemia Patients suffer double jeopardy of a pressure cone on one hand and CPM on the other Rapid correction is indicated with hyponatraemia known to be acute (12-24 hours), or in the presence of neurological symptoms Otherwise serum sodium correction should be limited to no more than 0.5 mmol/l/hour in the first 48 hours
  • 26. Is Serum [Na + ] < 125 mmol/l? Neurological symptoms? Duration of hyponatraemia? Yes Chronic hyponatraemia Yes No Emergency correction with 3% saline 1-2 ml/kg/hour until [Na] > 125 mmol/l Urgent correction with 3% saline 1-2 ml/kg/hour until symptoms resolve, continue at 0.5 mmol/l/hour thereafter <24 h >24 h or unknown Routine assessment and management No Adverse outcome unlikely
  • 27. Hypertonic Saline Therapy Start with 3% saline at 100 ml/hour 100 ml of 3% saline can be expected to increase serum [Na + ] by 2 mmol/l Formulae to estimate the correction doses of iv saline are unreliable Titrate the infusion rate on the basis of hourly serum [Na + ] measurements
  • 28. Problems Over-reliance on laboratory data Misclassification leading to the over-diagnosis of SIADH Inappropriate application of therapies Inadequate clinical supervision and laboratory monitoring
  • 29. Future Treatments Vasopressin (V2) receptor antagonists: Highly effective in SIADH and volume expanded hyponatraemia Standard rules for correction rates apply Hyponatraemia relapses on cessation Phenomenally expensive